Home Newsfeeds Needham Downgrades Chegg to Hold

Needham Downgrades Chegg to Hold

Needham analyst Ryan MacDonald downgrades Chegg (NYSE:CHGG) from Buy to Hold.

byBenzinga Newsdesk

January 18, 2023

1 minute read

Needham analyst Ryan MacDonald downgrades Chegg (NYSE:CHGG) from Buy to Hold.

Why Entrada Therapeutics Stock Is Diving After Hours

By Adam Eckert

December 19, 5:49 PM

Entrada Therapeutics Inc (NASDAQ: TRDA) shares are trading lower in Monday's after-hours session after the company said it received a clinical hold notice from the

TRDA

News

‘New York Mobile Sports Betting Revenue Hits Record $165.6M In September’ – iGamingBusiness

By Benzinga Newsdesk

October 9, 9:48 AM

https://igamingbusiness.com/sports-betting/new-york-sports-betting-revenue-record-september/Mobile sports betting revenue in New York reached a record $165.6m in September while handle hit a six-month nigh of

BYD

Merck Provides Update On Phase 3 KEYNOTE-412 Trial In Unresected Locally Advanced Head And Neck Squamous Cell Carcinoma; Trial Did Not Meet Primary Endpoint Of Event-Free Survival

By Bill Haddad

July 20, 6:46 AM

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Phase 3 KEYNOTE-412 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, with concurrent

MRK